AlphAIAlphAI — Financial news for AI agents
gurufocus.comSEP 142 min read$VRSK

A Look at Verisk Analytics Inc (VRSK) After 6.1% Gain -- GF Valu

Verisk Analytics Inc (VRSK) shares rose 6.1% to $187.03 on September 14, 2026. The stock is estimated to be 42.1% undervalued compared to its GF Value™ of $322.93. VRSK has a GF Score™ of 78/100, indicating above-average financial health and growth potential. Insider activity shows net selling of $5.6M over the past 12 months. The stock's P/E (TTM) is 28.7x, lower than its 5-year median of 43.0x.

Original reporting
gurufocus.com
Published Sep 14, 2026, 11:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 1:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMarket movers
Primary signal
$VRSK
Neutral
medium confidence
Mentioned
$VRSK
Relevance
4/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

The piece offers a valuation‑centric view but adds no new corporate event; its impact is limited to short‑term trader sentiment.

02

Market read

A modest intraday rally with a valuation narrative; relevance primarily to VRSK traders.

03

What to watch

The article omits recent earnings results, macro‑economic backdrop, and any upcoming product or contract news that could drive price.

Relevance 4/10Novelty 2/10Timing: Sep 14 2026 (same‑day price move)

Background

GuruFocus provides a valuation snapshot, GF Score, and insider activity summary for Verisk Analytics.

Company-level read

Ticker impact

$VRSKNeutralMedium confidence
Context

Verisk Analytics shares rose 6.1% on Sep 14, 2026, with GuruFocus reporting a new GF Value estimate and insider net selling data.

Expected impact

Potential modest upside if valuation gap attracts value buyers; downside risk from continued insider selling.

Evidence & confidence

Price move is documented, but no fresh catalyst beyond valuation metrics; insider activity may limit upside.

Market effects

Sector

Valuation focus may influence other data‑analytics and insurance‑tech stocks as investors compare P/E multiples.

Regional

Limited to US markets where VRSK trades.

Global

Low; article does not affect broader market trends.

Counterpoint

What could challenge this read

Despite the valuation gap, persistent insider selling could signal deeper issues, making the stock a potential short candidate.

Key entities

  • company
    Verisk Analytics Inc

    US‑listed data‑analytics firm (ticker VRSK).

Read at source← All news

Related articles

SEP 8
$VRSKMed

VRSK Maintained by Barclays -- Price Target Lowered to $225

Barclays maintained an Overweight rating on Verisk Analytics (VRSK) but lowered its price target from $275 to $225. The company's stock is trading at $179.17, which GuruFocus estimates is 44.4% undervalued. Verisk has a GF Score of 78/100, indicating strong profitability and growth, but lower momentum. Insider activity shows significant selling, with $2.55 million in sales over the past three months.

gurufocus.com2 min
AUG 29
$VRSKMed

Is Verisk’s Q2 Beat, Buyback and AI Push Altering The Investment Case For Verisk Analytics (VRSK)?

Verisk Analytics (VRSK) reported Q2 2026 earnings and revenue above estimates, reaffirmed its 2026 outlook, and announced a $200M share repurchase. The company emphasized growth in AI and data analytics for insurance clients. Verisk projects $3.8B in revenue and $1.3B in earnings by 2029, with a 24% upside to its current price. The company's high debt levels and interest expenses remain key risks.

simplywall.st2 min
AUG 28
$VRSKMedAI 8/10

Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) shares fell 4.7% since its last earnings report. Q2 2026 earnings beat estimates at $1.98 per share, up 5.3% YoY. Revenue rose 4.3% to $806.3M. Underwriting and claims revenues increased 3.5% and 6.3% respectively. EBITDA grew 4.2% but net income declined 9.8% due to higher taxes and interest. The company maintained 2026 guidance and approved a dividend. Estimates have trended downward, with a Zacks Rank #3 (Hold).

finance.yahoo.com3 min
AUG 19
$VRSKMedAI 8/10

Verisk Analytics v. AccuLynx: Sorry, You Actually DO Have To Comply With That Second Request

The Delaware Court of Chancery ordered Verisk Analytics to continue pursuing FTC clearance for its $2.35 billion acquisition of AccuLynx, despite Verisk's attempt to terminate the deal. The court ruled that Verisk's termination was invalid due to its willful conduct in ending negotiations with a competitor, ServiceTitan. Verisk must now comply with a costly Second Request process, which typically takes many months to complete. The court's decision is notable as it is the first to compel a buyer

marketscreener.com2 min